CompletedEarly Phase 1NCT01532024

Exploratory Clinical Study of Neutrophil Activation Probe (NAP) for Optical Molecular Imaging in Human Lungs

Studying Acute lung injury

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Edinburgh
Principal Investigator
Kev Dhaliwal, MD, M.D
University of Edinburgh
Intervention
Microdose of NAP(other)
Enrollment
15 target
Eligibility
18-60 years · MALE
Timeline
20142016

Study locations (3)

Collaborators

Medical Research Council

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01532024 on ClinicalTrials.gov

Other trials for Acute lung injury

Additional recruiting or active studies for the same condition.

See all trials for Acute lung injury

← Back to all trials